Vascular remodeling in experimentally induced subacute canine pulmonary hypertension

被引:23
|
作者
Gust, R
Schuster, DP
机构
[1] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Div Pulm & Crit Care, Dept Internal Med, St Louis, MO 63110 USA
关键词
dogs; monocrotaline; neointima; pulmonary hypertension; vascular remodeling;
D O I
10.1080/019021401459734
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
We quantified in vivo pulmonary vascular remodeling in a large animal model of pulmonary hypertension (PH). In group PH (n = 6), 3 mg/kg dehydromononcrotaline (DHMC) was administered to 12-week-old beagles via a right atrial injection. Eight weeks after DHMC in group PH, pulmonary artery pressure increased significantly (P < .05) fr om 18 +/- 2 mm Hg at baseline to 30 +/- 4 nm Hg. Medial wall thickness and medial wall area as a percentage of total vessel diameter or area was significantly higher (P < .05) In group PH (29 +/- 48 and 48 +/- 12%) than in a control group (n = 5) (7 +/- 1% and 14 +/- 1%). Neointimal proliferation was observed in 42% of pulmonary arterioles in the PH group hut never in the control group. We conclude that a single injection of DHMC in young beagles, in addition to the development of moderate degrees of PH after 8 weeks, causes significant pulmonary vascular remodeling, with features similar to those observed in patients with primary PH.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
  • [1] HDAC Inhibition With Quisinostat Reduces Pulmonary Vascular Remodeling in Experimentally Induced Pulmonary Arterial Hypertension
    Sun, Xiaoqing
    Hagdorn, Quint
    Van der Feen, Diederik
    Peters, Eva L.
    Schalij, Ingrid
    Schilders, Kim A.
    Dijke, Peter
    Noordegraaf, Anton Vonk
    De Man, Frances S.
    Berger, Rolf M.
    CIRCULATION, 2021, 144
  • [2] HDAC inhibitor quisinostat reduces pulmonary vascular remodeling in experimentally induced pulmonary arterial hypertension
    Sun, Xiao-Qing
    Peters, Eva L.
    Schalij, Ingrid
    De Man, Frances S.
    Goumans, Marie-Jose
    Kurakula, Kondababu
    Bogaard, Harm-Jan
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [3] Inhibition of Monoamine Oxidase-A Reduces Pulmonary Vascular Remodeling in Experimentally Induced Pulmonary Arterial Hypertension
    Sun, X.
    Peters, E.
    Schalij, I.
    Andersen, S.
    Bos, D. da Silva Goncalves
    Noordegraaf, A. Vonk
    De Man, F.
    van der Laarse, W.
    Bogaard, H. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [4] MnTBAP Reverses Pulmonary Vascular Remodeling and Improves Cardiac Function in Experimentally Induced Pulmonary Arterial Hypertension
    Gomez-Puerto, Maria Catalina
    Sun, Xiao-Qing
    Schalij, Ingrid
    Orriols, Mar
    Pan, Xiaoke
    Szulcek, Robert
    Goumans, Marie-Jose
    Bogaard, Harm-Jan
    Zhou, Qian
    ten Dijke, Peter
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (11) : 1 - 16
  • [5] PULMONARY VASCULAR CHANGES INDUCED BY EXPERIMENTALLY PRODUCED PULMONARY ARTERIAL HYPERTENSION
    DAMMANN, JF
    BAKER, JP
    MULLER, WH
    SURGERY GYNECOLOGY & OBSTETRICS, 1957, 105 (01): : 16 - 20
  • [6] Pulmonary Vascular Remodeling in Pulmonary Hypertension
    Jia, Zhuangzhuang
    Wang, Shuai
    Yan, Haifeng
    Cao, Yawen
    Zhang, Xuan
    Wang, Lin
    Zhang, Zeyu
    Lin, Shanshan
    Wang, Xianliang
    Mao, Jingyuan
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (02):
  • [7] Pulmonary vascular remodeling in pulmonary hypertension
    Rubin M. Tuder
    Cell and Tissue Research, 2017, 367 : 643 - 649
  • [8] Pulmonary vascular remodeling in pulmonary hypertension
    Tuder, Rubin M.
    CELL AND TISSUE RESEARCH, 2017, 367 (03) : 643 - 649
  • [9] Vascular remodeling in pulmonary hypertension
    Larissa A. Shimoda
    Steven S. Laurie
    Journal of Molecular Medicine, 2013, 91 : 297 - 309
  • [10] Vascular remodeling in pulmonary hypertension
    Shimoda, Larissa A.
    Laurie, Steven S.
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2013, 91 (03): : 297 - 309